跳至主要内容
临床试验/NCT03421275
NCT03421275Unknown4 期

Intranasal Fentanyl and Esketamine for Treatment of Acute Pain in Minor Trauma Patients

Anna Meuronen, MD1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2017年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
105
试验地点
1
主要终点
Numeric rating scale (NRS) change

研究概览

简要总结

Intranasal esketamine, fentanyl and placebo are compared in treatment of acute pain in adult patients with minor trauma. Study is blinded randomized placebo-controlled parallel design.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • NRS 5 or more, minor trauma, no need for immediate iv cannulation, weight 45-115 kg

排除标准

  • pregnancy, breastfeeding, head trauma, severe chronic obstructive pulmonary disease (COPD), gfr under 30, liver cirrhosis, mental illness other than mild/moderate depression, sleep apnea, unstable coronary artery disease (CAD), unstable heart failure (HF), intoxication, untreated hypertension, dementia, do not understand Finnish, contraindication to nasal spray, allergy to any of the medications, bradycardia, desaturation, suspected high intracranial pressure (ICP)

研究组 & 干预措施

Esketamine

Experimental

intravenous anaesthetic and analgetic

干预措施: Esketamine (Drug)

Fentanyl Citrate

Active Comparator

intravenous opioid analgetic

干预措施: Fentanyl Citrate (Drug)

Saline Nasal

Placebo Comparator

intravenous "Natriumklorid b. Braun 9 mg/ml"

干预措施: Saline Nasal (Drug)

结局指标

主要结局

Numeric rating scale (NRS) change

时间窗: 15 minutes and 30 minutes

Numeric rating scale is used to measure pain intensity. Scale is from 0-10. 0 = no pain, 10 = worst imegeable

次要结局

  • Amount of patients with NRS change more than -2(15 min, 30 min, 60 min)
  • Patient satisfaction (pain management)(120 min)
  • Need for rescue medication mg (oxycodone)(120 min)
  • Side effects(120 min)
  • Amount of study drug consumed (doses)(120 min)

研究者

发起方
Anna Meuronen, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Anna Meuronen, MD

Principal Investigator

Hospital District of Helsinki and Uusimaa

研究点 (1)

Loading locations...

相似试验